IBDEI04J ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5850,1,3,0)
 ;;=3^369.10
 ;;^UTILITY(U,$J,358.3,5850,1,4,0)
 ;;=4^One Eye-Blind/Oth Eye-Low Vision
 ;;^UTILITY(U,$J,358.3,5850,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,5851,0)
 ;;=369.12^^56^402^14
 ;;^UTILITY(U,$J,358.3,5851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5851,1,3,0)
 ;;=3^369.12
 ;;^UTILITY(U,$J,358.3,5851,1,4,0)
 ;;=4^One Eye-Severe/Oth Eye-TL
 ;;^UTILITY(U,$J,358.3,5851,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,5852,0)
 ;;=369.13^^56^402^12
 ;;^UTILITY(U,$J,358.3,5852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5852,1,3,0)
 ;;=3^369.13
 ;;^UTILITY(U,$J,358.3,5852,1,4,0)
 ;;=4^One Eye-Severe/Oth Eye-Near TL
 ;;^UTILITY(U,$J,358.3,5852,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,5853,0)
 ;;=369.14^^56^402^13
 ;;^UTILITY(U,$J,358.3,5853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5853,1,3,0)
 ;;=3^369.14
 ;;^UTILITY(U,$J,358.3,5853,1,4,0)
 ;;=4^One Eye-Severe/Oth Eye-Prfnd
 ;;^UTILITY(U,$J,358.3,5853,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,5854,0)
 ;;=369.22^^56^402^16
 ;;^UTILITY(U,$J,358.3,5854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5854,1,3,0)
 ;;=3^369.22
 ;;^UTILITY(U,$J,358.3,5854,1,4,0)
 ;;=4^Severe Impair-Both Eyes
 ;;^UTILITY(U,$J,358.3,5854,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,5855,0)
 ;;=1^1^56^403^1^DIABETES TYPE 2^0^1
 ;;^UTILITY(U,$J,358.3,5855,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,5856,0)
 ;;=250.00^^56^403^2
 ;;^UTILITY(U,$J,358.3,5856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5856,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,5856,1,4,0)
 ;;=4^DM 2 wo ophth manif
 ;;^UTILITY(U,$J,358.3,5856,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,5857,0)
 ;;=250.50^^56^403^3
 ;;^UTILITY(U,$J,358.3,5857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5857,1,3,0)
 ;;=3^250.50
 ;;^UTILITY(U,$J,358.3,5857,1,4,0)
 ;;=4^DM 2 with ophth manif
 ;;^UTILITY(U,$J,358.3,5857,2)
 ;;=^331799
 ;;^UTILITY(U,$J,358.3,5858,0)
 ;;=362.01^^56^403^11
 ;;^UTILITY(U,$J,358.3,5858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5858,1,3,0)
 ;;=3^362.01
 ;;^UTILITY(U,$J,358.3,5858,1,4,0)
 ;;=4^Macular Edema (CSME)
 ;;^UTILITY(U,$J,358.3,5858,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,5859,0)
 ;;=362.02^^56^403^12
 ;;^UTILITY(U,$J,358.3,5859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5859,1,3,0)
 ;;=3^362.02
 ;;^UTILITY(U,$J,358.3,5859,1,4,0)
 ;;=4^Proliferative Diab Ret
 ;;^UTILITY(U,$J,358.3,5859,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,5860,0)
 ;;=7^1^56^403^7^DIABETES TYPE 1^^1
 ;;^UTILITY(U,$J,358.3,5860,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,5861,0)
 ;;=250.01^^56^403^8
 ;;^UTILITY(U,$J,358.3,5861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5861,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,5861,1,4,0)
 ;;=4^DM 1 wo Ophth Manif
 ;;^UTILITY(U,$J,358.3,5861,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,5862,0)
 ;;=250.51^^56^403^9
 ;;^UTILITY(U,$J,358.3,5862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5862,1,3,0)
 ;;=3^250.51
 ;;^UTILITY(U,$J,358.3,5862,1,4,0)
 ;;=4^DM 1 with Ophth Manif
 ;;^UTILITY(U,$J,358.3,5862,2)
 ;;=^331800
 ;;^UTILITY(U,$J,358.3,5863,0)
 ;;=365.22^^56^404^1
 ;;^UTILITY(U,$J,358.3,5863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5863,1,3,0)
 ;;=3^365.22
 ;;^UTILITY(U,$J,358.3,5863,1,4,0)
 ;;=4^Acute Angl-Clos Glaucoma
 ;;^UTILITY(U,$J,358.3,5863,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,5864,0)
 ;;=365.02^^56^404^2
 ;;^UTILITY(U,$J,358.3,5864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5864,1,3,0)
 ;;=3^365.02
 ;;^UTILITY(U,$J,358.3,5864,1,4,0)
 ;;=4^Anatomical Narrow Angle
 ;;^UTILITY(U,$J,358.3,5864,2)
 ;;=^268748
 ;;^UTILITY(U,$J,358.3,5865,0)
 ;;=365.9^^56^404^6
 ;;^UTILITY(U,$J,358.3,5865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5865,1,3,0)
 ;;=3^365.9
 ;;^UTILITY(U,$J,358.3,5865,1,4,0)
 ;;=4^Glaucoma Unspec
 ;;^UTILITY(U,$J,358.3,5865,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,5866,0)
 ;;=365.12^^56^404^8
 ;;^UTILITY(U,$J,358.3,5866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5866,1,3,0)
 ;;=3^365.12
 ;;^UTILITY(U,$J,358.3,5866,1,4,0)
 ;;=4^Low Tension Glaucoma
 ;;^UTILITY(U,$J,358.3,5866,2)
 ;;=^265223
 ;;^UTILITY(U,$J,358.3,5867,0)
 ;;=365.04^^56^404^11
 ;;^UTILITY(U,$J,358.3,5867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5867,1,3,0)
 ;;=3^365.04
 ;;^UTILITY(U,$J,358.3,5867,1,4,0)
 ;;=4^Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,5867,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,5868,0)
 ;;=365.10^^56^404^12
 ;;^UTILITY(U,$J,358.3,5868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5868,1,3,0)
 ;;=3^365.10
 ;;^UTILITY(U,$J,358.3,5868,1,4,0)
 ;;=4^Open-Angle Glaucoma Nos
 ;;^UTILITY(U,$J,358.3,5868,2)
 ;;=^51206
 ;;^UTILITY(U,$J,358.3,5869,0)
 ;;=365.13^^56^404^14
 ;;^UTILITY(U,$J,358.3,5869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5869,1,3,0)
 ;;=3^365.13
 ;;^UTILITY(U,$J,358.3,5869,1,4,0)
 ;;=4^Pigmentary Glaucoma
 ;;^UTILITY(U,$J,358.3,5869,2)
 ;;=^51211
 ;;^UTILITY(U,$J,358.3,5870,0)
 ;;=365.00^^56^404^15
 ;;^UTILITY(U,$J,358.3,5870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5870,1,3,0)
 ;;=3^365.00
 ;;^UTILITY(U,$J,358.3,5870,1,4,0)
 ;;=4^Preglaucoma Nos
 ;;^UTILITY(U,$J,358.3,5870,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,5871,0)
 ;;=V80.1^^56^404^17
 ;;^UTILITY(U,$J,358.3,5871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5871,1,3,0)
 ;;=3^V80.1
 ;;^UTILITY(U,$J,358.3,5871,1,4,0)
 ;;=4^Screening For Glaucoma
 ;;^UTILITY(U,$J,358.3,5871,2)
 ;;=^295684
 ;;^UTILITY(U,$J,358.3,5872,0)
 ;;=365.05^^56^404^13
 ;;^UTILITY(U,$J,358.3,5872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5872,1,3,0)
 ;;=3^365.05
 ;;^UTILITY(U,$J,358.3,5872,1,4,0)
 ;;=4^Opn Angle w/ Brdrlne Hi Risk
 ;;^UTILITY(U,$J,358.3,5872,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,5873,0)
 ;;=365.06^^56^404^16
 ;;^UTILITY(U,$J,358.3,5873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5873,1,3,0)
 ;;=3^365.06
 ;;^UTILITY(U,$J,358.3,5873,1,4,0)
 ;;=4^Prim Angle Clos w/o Damage
 ;;^UTILITY(U,$J,358.3,5873,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,5874,0)
 ;;=365.70^^56^404^5
 ;;^UTILITY(U,$J,358.3,5874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5874,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,5874,1,4,0)
 ;;=4^Glaucoma Stage NOS
 ;;^UTILITY(U,$J,358.3,5874,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,5875,0)
 ;;=365.71^^56^404^9
 ;;^UTILITY(U,$J,358.3,5875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5875,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,5875,1,4,0)
 ;;=4^Mild Stage Glaucoma
 ;;^UTILITY(U,$J,358.3,5875,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,5876,0)
 ;;=365.72^^56^404^10
 ;;^UTILITY(U,$J,358.3,5876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5876,1,3,0)
 ;;=3^365.72
 ;;^UTILITY(U,$J,358.3,5876,1,4,0)
 ;;=4^Moderate Stage Glaucoma
 ;;^UTILITY(U,$J,358.3,5876,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,5877,0)
 ;;=365.73^^56^404^18
 ;;^UTILITY(U,$J,358.3,5877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5877,1,3,0)
 ;;=3^365.73
 ;;^UTILITY(U,$J,358.3,5877,1,4,0)
 ;;=4^Severe Stage Glaucoma
 ;;^UTILITY(U,$J,358.3,5877,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,5878,0)
 ;;=365.74^^56^404^7
 ;;^UTILITY(U,$J,358.3,5878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5878,1,3,0)
 ;;=3^365.74
 ;;^UTILITY(U,$J,358.3,5878,1,4,0)
 ;;=4^Indeterm Stage Glaucoma
 ;;^UTILITY(U,$J,358.3,5878,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,5879,0)
 ;;=V19.11^^56^404^4
 ;;^UTILITY(U,$J,358.3,5879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5879,1,3,0)
 ;;=3^V19.11
 ;;^UTILITY(U,$J,358.3,5879,1,4,0)
 ;;=4^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,5879,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,5880,0)
 ;;=V19.19^^56^404^3
 ;;^UTILITY(U,$J,358.3,5880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5880,1,3,0)
 ;;=3^V19.19
 ;;^UTILITY(U,$J,358.3,5880,1,4,0)
 ;;=4^Family Hx of Eye Disorder NEC
 ;;^UTILITY(U,$J,358.3,5880,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,5881,0)
 ;;=362.34^^56^405^1
 ;;^UTILITY(U,$J,358.3,5881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5881,1,3,0)
 ;;=3^362.34
 ;;^UTILITY(U,$J,358.3,5881,1,4,0)
 ;;=4^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,5881,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,5882,0)
 ;;=368.13^^56^405^2
 ;;^UTILITY(U,$J,358.3,5882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5882,1,3,0)
 ;;=3^368.13
 ;;^UTILITY(U,$J,358.3,5882,1,4,0)
 ;;=4^Asthenopia/Photophobia
 ;;^UTILITY(U,$J,358.3,5882,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,5883,0)
 ;;=368.30^^56^405^3
 ;;^UTILITY(U,$J,358.3,5883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5883,1,3,0)
 ;;=3^368.30
 ;;^UTILITY(U,$J,358.3,5883,1,4,0)
 ;;=4^Binocular Vision Dis Nos
 ;;^UTILITY(U,$J,358.3,5883,2)
 ;;=^14407
 ;;^UTILITY(U,$J,358.3,5884,0)
 ;;=368.59^^56^405^4
 ;;^UTILITY(U,$J,358.3,5884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5884,1,3,0)
 ;;=3^368.59
 ;;^UTILITY(U,$J,358.3,5884,1,4,0)
 ;;=4^Other Specif Color Deficiency
 ;;^UTILITY(U,$J,358.3,5884,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,5885,0)
 ;;=368.2^^56^405^5
 ;;^UTILITY(U,$J,358.3,5885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5885,1,3,0)
 ;;=3^368.2
 ;;^UTILITY(U,$J,358.3,5885,1,4,0)
 ;;=4^Diplopia
 ;;^UTILITY(U,$J,358.3,5885,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,5886,0)
 ;;=784.0^^56^405^6
 ;;^UTILITY(U,$J,358.3,5886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5886,1,3,0)
 ;;=3^784.0
 ;;^UTILITY(U,$J,358.3,5886,1,4,0)
 ;;=4^Headache
 ;;^UTILITY(U,$J,358.3,5886,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,5887,0)
 ;;=368.14^^56^405^7
 ;;^UTILITY(U,$J,358.3,5887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5887,1,3,0)
 ;;=3^368.14
 ;;^UTILITY(U,$J,358.3,5887,1,4,0)
 ;;=4^Metamorphopsia
 ;;^UTILITY(U,$J,358.3,5887,2)
 ;;=^268836
 ;;^UTILITY(U,$J,358.3,5888,0)
 ;;=346.90^^56^405^8
 ;;^UTILITY(U,$J,358.3,5888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5888,1,3,0)
 ;;=3^346.90
 ;;^UTILITY(U,$J,358.3,5888,1,4,0)
 ;;=4^Migraine Unspec W/O Intract.
 ;;^UTILITY(U,$J,358.3,5888,2)
 ;;=^293880
 ;;^UTILITY(U,$J,358.3,5889,0)
 ;;=346.91^^56^405^9
 ;;^UTILITY(U,$J,358.3,5889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5889,1,3,0)
 ;;=3^346.91
 ;;^UTILITY(U,$J,358.3,5889,1,4,0)
 ;;=4^Migraine Unspec. Intractable
